{"transactions":[{"id":3484842,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-19T18:29:16.000Z","date":"2019-06-19","kind":"purchase","acquired":true,"shares":4957,"price":8.1693,"value":40495.2201,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $8.00 to $8.27, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22860013,"source":{"system":"sec-edgar","filing":"0000903423-19-000253","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000253/urov4.xml","form_type":"4"}},{"id":3484841,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-19T18:29:16.000Z","date":"2019-06-18","kind":"purchase","acquired":true,"shares":6706,"price":8.2107,"value":55060.9542,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $8.09 to $8.29, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22855056,"source":{"system":"sec-edgar","filing":"0000903423-19-000253","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000253/urov4.xml","form_type":"4"}},{"id":3484840,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-19T18:29:16.000Z","date":"2019-06-17","kind":"purchase","acquired":true,"shares":6541,"price":8.5346,"value":55824.8186,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $8.11 to $8.70, inclusive. The reporting person undertakes to provide to Urovant Sciences Ltd. (\"Urovant\"), any security holder of Urovant, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22848350,"source":{"system":"sec-edgar","filing":"0000903423-19-000253","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000253/urov4.xml","form_type":"4"}},{"id":3490000,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-14T18:16:09.000Z","date":"2019-06-14","kind":"purchase","acquired":true,"shares":7144,"price":7.9107,"value":56514.0408,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.65 to $8.00, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22841809,"source":{"system":"sec-edgar","filing":"0000903423-19-000248","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000248/urov4.xml","form_type":"4"}},{"id":3489999,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-14T18:16:09.000Z","date":"2019-06-13","kind":"purchase","acquired":true,"shares":7367,"price":7.9466,"value":58542.6022,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.67 to $8.39, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22834665,"source":{"system":"sec-edgar","filing":"0000903423-19-000248","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000248/urov4.xml","form_type":"4"}},{"id":3489998,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-14T18:16:09.000Z","date":"2019-06-12","kind":"purchase","acquired":true,"shares":7500,"price":8.2992,"value":62244.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $8.16 to $8.77, inclusive. The reporting person undertakes to provide to Urovant Sciences Ltd. (\"Urovant\"), any security holder of Urovant, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22827298,"source":{"system":"sec-edgar","filing":"0000903423-19-000248","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000248/urov4.xml","form_type":"4"}},{"id":3491658,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, $0.000017727 par value per share","published_at":"2019-06-13T15:45:59.000Z","date":"2019-06-04","kind":"purchase","acquired":true,"shares":2424242,"price":8.25,"value":19999996.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares of common stock (the \"Common Shares\") were purchased by Roivant Sciences Ltd. (\"Roivant\") in connection with an underwritten public offering of Common Shares by Myovant Sciences Ltd. The Common Shares are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"As the approval of the Reporting Persons' Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial\nownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":40765599,"source":{"system":"sec-edgar","filing":"0000903423-19-000244","document":"vgpmyov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000244/vgpmyov4.xml","form_type":"4"}},{"id":3494550,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-11T18:14:50.000Z","date":"2019-06-11","kind":"purchase","acquired":true,"shares":7189,"price":8.5817,"value":61693.8413,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $8.41 to $8.75, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22819798,"source":{"system":"sec-edgar","filing":"0000903423-19-000241","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000241/urov4.xml","form_type":"4"}},{"id":3494549,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-11T18:14:50.000Z","date":"2019-06-10","kind":"purchase","acquired":true,"shares":7500,"price":8.3459,"value":62594.25,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.89 to $8.68, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22812609,"source":{"system":"sec-edgar","filing":"0000903423-19-000241","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000241/urov4.xml","form_type":"4"}},{"id":3494548,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-11T18:14:50.000Z","date":"2019-06-07","kind":"purchase","acquired":true,"shares":6649,"price":7.965,"value":52959.285,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.73 to $8.10, inclusive. The reporting person undertakes to provide to Urovant Sciences Ltd. (\"Urovant\"), any security holder of Urovant, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22805109,"source":{"system":"sec-edgar","filing":"0000903423-19-000241","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000241/urov4.xml","form_type":"4"}},{"id":3499180,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-06T18:16:36.000Z","date":"2019-06-06","kind":"purchase","acquired":true,"shares":7082,"price":7.9951,"value":56621.2982,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.73 to $8.57, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial\nownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22798460,"source":{"system":"sec-edgar","filing":"0000903423-19-000239","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000239/urov4.xml","form_type":"4"}},{"id":3499179,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-06T18:16:36.000Z","date":"2019-06-05","kind":"purchase","acquired":true,"shares":6540,"price":8.015,"value":52418.1,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.68 to $8.33, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial\nownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22791378,"source":{"system":"sec-edgar","filing":"0000903423-19-000239","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000239/urov4.xml","form_type":"4"}},{"id":3499178,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-06T18:16:36.000Z","date":"2019-06-04","kind":"purchase","acquired":true,"shares":7500,"price":7.5881,"value":56910.75,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.42 to $7.71, inclusive. The reporting person undertakes to provide to Urovant Sciences Ltd. (\"Urovant\"), any security holder of Urovant, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial\nownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22784838,"source":{"system":"sec-edgar","filing":"0000903423-19-000239","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000239/urov4.xml","form_type":"4"}},{"id":3505147,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-03T18:23:00.000Z","date":"2019-06-03","kind":"purchase","acquired":true,"shares":5424,"price":7.7092,"value":41814.7008,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 6 and 7 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.64 to $7.74, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22777338,"source":{"system":"sec-edgar","filing":"0000903423-19-000237","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000237/urov4.xml","form_type":"4"}},{"id":3505146,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-03T18:23:00.000Z","date":"2019-05-31","kind":"purchase","acquired":true,"shares":5071,"price":7.6991,"value":39042.1361,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 6 and 7 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.41 to $7.84, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22771914,"source":{"system":"sec-edgar","filing":"0000903423-19-000237","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000237/urov4.xml","form_type":"4"}},{"id":3505145,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-03T18:23:00.000Z","date":"2019-05-30","kind":"purchase","acquired":true,"shares":300,"price":8.9066,"value":2671.98,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 6 and 7 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $8.71 to $9.03, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22766843,"source":{"system":"sec-edgar","filing":"0000903423-19-000237","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000237/urov4.xml","form_type":"4"}},{"id":3505144,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-06-03T18:23:00.000Z","date":"2019-05-30","kind":"purchase","acquired":true,"shares":6951,"price":7.9726,"value":55417.5426,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 6 and 7 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.70 to $8.70, inclusive. The reporting person undertakes to provide to Urovant Sciences Ltd. (\"Urovant\"), any security holder of Urovant, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22766543,"source":{"system":"sec-edgar","filing":"0000903423-19-000237","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000237/urov4.xml","form_type":"4"}},{"id":3509081,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-05-29T18:23:42.000Z","date":"2019-05-29","kind":"purchase","acquired":true,"shares":6882,"price":7.5535,"value":51983.187,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.40 to $7.69, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22759592,"source":{"system":"sec-edgar","filing":"0000903423-19-000233","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000233/urov4.xml","form_type":"4"}},{"id":3509080,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-05-29T18:23:42.000Z","date":"2019-05-28","kind":"purchase","acquired":true,"shares":3807,"price":7.6818,"value":29244.6126,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.65 to $7.70, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22752710,"source":{"system":"sec-edgar","filing":"0000903423-19-000233","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000233/urov4.xml","form_type":"4"}},{"id":3509079,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-05-29T18:23:42.000Z","date":"2019-05-24","kind":"purchase","acquired":true,"shares":3796,"price":7.7011,"value":29233.3756,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made by Roivant Sciences Ltd. (\"Roivant\") under a trading plan established by Roivant pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), and in accordance with the safe harbor of Rule 10b-18 under the Exchange Act. The purchases were made by Roivant and not by the Reporting Person. See footnotes 5 and 6 for information on the Reporting Person's ownership via Roivant of the purchased Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.66 to $7.74, inclusive. The reporting person undertakes to provide to Urovant Sciences Ltd. (\"Urovant\"), any security holder of Urovant, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"These shares of common stock (the \"Common Shares\") of Urovant are directly beneficially owned by Roivant and indirectly beneficially owned by the Reporting Persons. The Reporting Persons acquired Roivant common shares on December 8, 2015. Pursuant to Roivant's internal governance documents, following the appointment to Roivant's board of directors of one or more directors meeting certain independence criteria (each an \"Independent Director\" and collectively the \"Independent Directors\"), dispositions of the Common Shares require the approval of a majority of Roivant's board of directors, including (i) at least two Independent Directors, or, (ii) if there is only one independent director, that sole Independent Director. The Reporting Persons had an Independent Director appointed to Roivant's board of directors effective July 8, 2016."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"As the approval of the Reporting Person's Independent Director, and, to the extent one other Independent Director is serving, that other Independent Director, is needed for Roivant to dispose of the Common Shares, the Reporting Persons may be deemed to have dispositive power over, and to be indirect beneficial owners of, the Common Shares directly beneficially owned by Roivant. The Reporting Persons disclaim beneficial ownership of the shares owned by Roivant, except to the extent of their respective pecuniary interest therein. Additionally, this filing shall not be deemed an admission that the Reporting Persons and any other Independent Director constitute a \"group\" for purposes of Section 13(d) or Section 13(g) of the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."}],"balance_after":22748903,"source":{"system":"sec-edgar","filing":"0000903423-19-000233","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000233/urov4.xml","form_type":"4"}},{"id":3513745,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-05-23T18:36:42.000Z","date":"2019-05-23","kind":"purchase","acquired":true,"shares":4802,"price":7.7576,"value":37251.9952,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The transaction was a series of open market purchases made under a trading plan established pursuant to Rule 10b5-1 under the Exchange Act and in accordance with the safe harbor of Rule 10b-18"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.645 to $7.98, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Persons do not directly own any shares of common stock (the \"Common Shares\") of Urovant. The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 22,745,107 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's by-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's by-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose"}],"balance_after":22745107,"source":{"system":"sec-edgar","filing":"0000903423-19-000228","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000228/urov4.xml","form_type":"4"}},{"id":3513744,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-05-23T18:36:42.000Z","date":"2019-05-22","kind":"purchase","acquired":true,"shares":5033,"price":8.0584,"value":40557.9272,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The transaction was a series of open market purchases made under a trading plan established pursuant to Rule 10b5-1 under the Exchange Act and in accordance with the safe harbor of Rule 10b-18"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.825 to $8.43, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the SEC, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Persons do not directly own any shares of common stock (the \"Common Shares\") of Urovant. The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 22,745,107 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's by-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's by-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose"}],"balance_after":22740305,"source":{"system":"sec-edgar","filing":"0000903423-19-000228","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000228/urov4.xml","form_type":"4"}},{"id":3513743,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-05-23T18:36:42.000Z","date":"2019-05-21","kind":"purchase","acquired":true,"shares":9995,"price":8.5151,"value":85108.4245,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made in accordance with the safe harbor of Rule 10b-18 (\"Rule 10b-18\") under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $8.31 to $8.69, inclusive. The reporting person undertakes to provide to Urovant Sciences Ltd. (\"Urovant\"), any security holder of Urovant, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Persons do not directly own any shares of common stock (the \"Common Shares\") of Urovant. The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 22,745,107 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's by-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's by-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose"}],"balance_after":22735272,"source":{"system":"sec-edgar","filing":"0000903423-19-000228","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000228/urov4.xml","form_type":"4"}},{"id":3518913,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-05-20T21:23:42.000Z","date":"2019-05-20","kind":"purchase","acquired":true,"shares":1715,"price":8.3867,"value":14383.1905,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made in accordance with the safe harbor of Rule 10b-18 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $8.36 to $8.47, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (5) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Persons do not directly own any shares of common stock (the \"Common Shares\") of Urovant. The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 22,725,277 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's by-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's by-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"source":{"system":"sec-edgar","filing":"0000903423-19-000224","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000224/urov4.xml","form_type":"4"}},{"id":3518912,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-05-20T21:23:42.000Z","date":"2019-05-20","kind":"purchase","acquired":true,"shares":8285,"price":7.9833,"value":66141.6405,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made in accordance with the safe harbor of Rule 10b-18 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.35 to $8.35, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (4) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Persons do not directly own any shares of common stock (the \"Common Shares\") of Urovant. The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 22,725,277 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's by-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's by-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"source":{"system":"sec-edgar","filing":"0000903423-19-000224","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000224/urov4.xml","form_type":"4"}},{"id":3518911,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-05-20T21:23:42.000Z","date":"2019-05-17","kind":"purchase","acquired":true,"shares":6200,"price":7.3615,"value":45641.3,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made in accordance with the safe harbor of Rule 10b-18 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $7.03 to $7.85, inclusive. The reporting person undertakes to provide to Urovant, any security holder of Urovant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Persons do not directly own any shares of common stock (the \"Common Shares\") of Urovant. The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 22,725,277 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's by-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's by-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"source":{"system":"sec-edgar","filing":"0000903423-19-000224","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000224/urov4.xml","form_type":"4"}},{"id":3518910,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":7,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.000037453 per share","published_at":"2019-05-20T21:23:42.000Z","date":"2019-05-16","kind":"purchase","acquired":true,"shares":5408,"price":6.7896,"value":36718.1568,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction was a series of open market purchases made in accordance with the safe harbor of Rule 10b-18 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These Common Shares were purchased in multiple transactions at prices ranging from $6.70 to $6.93, inclusive. The reporting person undertakes to provide to Urovant Sciences Ltd. (\"Urovant\"), any security holder of Urovant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Persons do not directly own any shares of common stock (the \"Common Shares\") of Urovant. The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 22,725,277 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's by-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's by-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\"). VGP is the general partner of VGE and VGE II and the investment manager of VGE III and VGEM. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":22709077,"source":{"system":"sec-edgar","filing":"0000903423-19-000224","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000224/urov4.xml","form_type":"4"}},{"id":3588183,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89798,"kind":"organization","name":"Viking Global Equities Master Ltd.","position":5,"cik":"0001759530","reported_name":"Viking Global Equities Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":6,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":7,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":8,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":9,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":10,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.00001 per share","published_at":"2019-03-19T17:06:37.000Z","date":"2019-03-18","kind":"purchase","acquired":true,"shares":6666667,"price":1.5,"value":10000000.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Persons (as defined below) do not directly own any shares of common stock (the \"Common Shares\") of Axovant Sciences Ltd. (the \"Issuer\"). The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 105,952,381 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's by-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's by-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Global Equities Master Ltd. (\"VGEM\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III, VGEM and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"VGP is the general partner of VGE, VGE II and VGEM and the investment manager of VGE III. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":105952381,"source":{"system":"sec-edgar","filing":"0000903423-19-000152","document":"axon2.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342319000152/axon2.xml","form_type":"4"}},{"id":3723573,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":5,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74391,"kind":"person","name":"HALVORSEN OLE ANDREAS","position":7,"cik":"0001133006","reported_name":"HALVORSEN OLE ANDREAS","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74392,"kind":"person","name":"Ott David C.","position":8,"cik":"0001621842","reported_name":"Ott David C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74393,"kind":"person","name":"Shabet Rose Sharon","position":9,"cik":"0001711393","reported_name":"Shabet Rose Sharon","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.00001 per share","published_at":"2018-12-20T09:38:11.000Z","date":"2018-12-18","kind":"purchase","acquired":true,"shares":10000000,"price":1,"value":10000000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Persons (as defined below) do not directly own any shares of common stock (the \"Common Shares\") of Axovant Sciences Ltd. (the \"Issuer\"). The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 99,285,714 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's bye-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's bye-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\"). VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"VGP is the general partner of VGE and VGE II and the investment manager of VGE III. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":99285714,"source":{"system":"sec-edgar","filing":"0000903423-18-000641","document":"axon2.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342318000641/axon2.xml","form_type":"4"}},{"id":3799122,"issuer":{"id":140739,"kind":"organization","name":"Urovant Sciences Ltd.","symbol":"UROV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":5,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":6,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, $0.000037453 par value per share","published_at":"2018-10-03T17:52:41.000Z","date":"2018-10-01","kind":"purchase","acquired":true,"shares":2678571,"price":14,"value":37499994.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Persons (as defined below) do not directly own any shares of common stock (the \"Common Shares\") of Urovant Sciences Ltd. (the \"Issuer\"). The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 22,703,669 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's bye-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's bye-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Persons (as defined below) do not directly own any shares of common stock (the \"Common Shares\") of Urovant Sciences Ltd. (the \"Issuer\"). The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 22,703,669 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's bye-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's bye-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Persons (as defined below) do not directly own any shares of common stock (the \"Common Shares\") of Urovant Sciences Ltd. (the \"Issuer\"). The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 22,703,669 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's bye-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's bye-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\"). VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"VGP is the general partner of VGE and VGE II and the investment manager of VGE III. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":22703669,"source":{"system":"sec-edgar","filing":"0000903423-18-000528","document":"urov4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342318000528/urov4.xml","form_type":"4"}},{"id":3902078,"issuer":{"id":130622,"kind":"organization","name":"Sio Gene Therapies Inc.","symbol":"SIOX"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":5,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, par value $0.00001 per share","published_at":"2018-06-07T08:21:30.000Z","date":"2018-06-05","kind":"purchase","acquired":true,"shares":14285714,"price":1.75,"value":24999999.5,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Persons (as defined below) do not directly own any shares of common stock (the \"Common Shares\") of Axovant Sciences Ltd. (the \"Issuer\"). The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 89,285,714 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's bye-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's bye-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Persons (as defined below) do not directly own any shares of common stock (the \"Common Shares\") of Axovant Sciences Ltd. (the \"Issuer\"). The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 89,285,714 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's bye-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's bye-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The Reporting Persons (as defined below) do not directly own any shares of common stock (the \"Common Shares\") of Axovant Sciences Ltd. (the \"Issuer\"). The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares (the \"Roivant Common Shares\") on December 8, 2015. Roivant directly holds the 89,285,714 Common Shares reported herein. Due to certain governance arrangements set forth in Roivant's bye-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's bye-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Common Shares held by Roivant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\"). VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"VGP is the general partner of VGE and VGE II and the investment manager of VGE III. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":89285714,"source":{"system":"sec-edgar","filing":"0000903423-18-000325","document":"axon2.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342318000325/axon2.xml","form_type":"4"}},{"id":3970344,"issuer":{"id":115677,"kind":"organization","name":"Myovant Sciences Ltd.","symbol":"MYOV"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":5,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, $0.000017727 par value per share","published_at":"2018-04-04T21:58:34.000Z","date":"2018-04-02","kind":"purchase","acquired":true,"shares":1110015,"price":20.27,"value":22500004.05,"ownership":{"direct":false,"nature":"Explanation of Responses"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\"). VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Persons do not directly own any shares of common stock, $0.000017727 par value per share (the \"Common Shares\"), of Myovant Sciences Ltd. (the \"Issuer\"). The Reporting Persons acquired Roivant Sciences Ltd. (\"Roivant\") common shares on December 8, 2015. Roivant directly holds the 38,341,357 Common Shares (the \"Roivant Common Shares\") reported herein. Due to certain governance arrangements set forth in Roivant's bye-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's bye-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Roivant Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"VGP is the general partner of VGE and VGE II and the investment manager of VGE III. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":38341357,"source":{"system":"sec-edgar","filing":"0000903423-18-000191","document":"vikingnyovanttf4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342318000191/vikingnyovanttf4.xml","form_type":"4"}},{"id":4099539,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":5,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Participating Convertible Preferred Shares","published_at":"2018-01-16T08:34:41.000Z","date":"2018-01-12","kind":"purchase","acquired":true,"shares":664000,"price":100,"value":66400000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents series A participating convertible preferred shares (the \"Preferred Shares\") purchased by Roivant Sciences Ltd. (\"Roivant\") for $100.00 per Preferred Share (the \"Purchase Price\"), which price is subject to increase to reflect the addition of any unpaid participating cash dividends and unpaid participating in-kind dividends."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Subject to earlier conversion at Roivant's option upon the occurrence of certain limited events set forth in the amendment to the Notice of Articles and the Articles of the Issuer (the \"Preferred Shares Articles Amendment\"), the Preferred Shares mandatorily convert on October 16, 2021, to the extent not already converted, into (i) unpaid accrued participating in-kind dividends and cash for any unpaid accrued cash dividends, as set forth in the Preferred Shares Article Amendment, and (ii) common shares of the Issuer, no par value (the \"Common Shares\"), which is determined by dividing (a) the Purchase Price, plus an amount equal to 8.75% of the Purchase Price per year, compounded annually, by (b) the conversion price in effect at the time of conversion. Each Preferred Share is initially convertible based on a conversion price of $7.13, subject to adjustment for certain distributions and other transactions by the Issuer on or with respect to the Common Shares."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents series A participating convertible preferred shares (the \"Preferred Shares\") purchased by Roivant Sciences Ltd. (\"Roivant\") for $100.00 per Preferred Share (the \"Purchase Price\"), which price is subject to increase to reflect the addition of any unpaid participating cash dividends and unpaid participating in-kind dividends."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to earlier conversion at Roivant's option upon the occurrence of certain limited events set forth in the amendment to the Notice of Articles and the Articles of the Issuer (the \"Preferred Shares Articles Amendment\"), the Preferred Shares mandatorily convert on October 16, 2021, to the extent not already converted, into (i) unpaid accrued participating in-kind dividends and cash for any unpaid accrued cash dividends, as set forth in the Preferred Shares Article Amendment, and (ii) common shares of the Issuer, no par value (the \"Common Shares\"), which is determined by dividing (a) the Purchase Price, plus an amount equal to 8.75% of the Purchase Price per year, compounded annually, by (b) the conversion price in effect at the time of conversion. Each Preferred Share is initially convertible based on a conversion price of $7.13, subject to adjustment for certain distributions and other transactions by the Issuer on or with respect to the Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents series A participating convertible preferred shares (the \"Preferred Shares\") purchased by Roivant Sciences Ltd. (\"Roivant\") for $100.00 per Preferred Share (the \"Purchase Price\"), which price is subject to increase to reflect the addition of any unpaid participating cash dividends and unpaid participating in-kind dividends."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Subject to earlier conversion at Roivant's option upon the occurrence of certain limited events set forth in the amendment to the Notice of Articles and the Articles of the Issuer (the \"Preferred Shares Articles Amendment\"), the Preferred Shares mandatorily convert on October 16, 2021, to the extent not already converted, into (i) unpaid accrued participating in-kind dividends and cash for any unpaid accrued cash dividends, as set forth in the Preferred Shares Article Amendment, and (ii) common shares of the Issuer, no par value (the \"Common Shares\"), which is determined by dividing (a) the Purchase Price, plus an amount equal to 8.75% of the Purchase Price per year, compounded annually, by (b) the conversion price in effect at the time of conversion. Each Preferred Share is initially convertible based on a conversion price of $7.13, subject to adjustment for certain distributions and other transactions by the Issuer on or with respect to the Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents series A participating convertible preferred shares (the \"Preferred Shares\") purchased by Roivant Sciences Ltd. (\"Roivant\") for $100.00 per Preferred Share (the \"Purchase Price\"), which price is subject to increase to reflect the addition of any unpaid participating cash dividends and unpaid participating in-kind dividends."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to earlier conversion at Roivant's option upon the occurrence of certain limited events set forth in the amendment to the Notice of Articles and the Articles of the Issuer (the \"Preferred Shares Articles Amendment\"), the Preferred Shares mandatorily convert on October 16, 2021, to the extent not already converted, into (i) unpaid accrued participating in-kind dividends and cash for any unpaid accrued cash dividends, as set forth in the Preferred Shares Article Amendment, and (ii) common shares of the Issuer, no par value (the \"Common Shares\"), which is determined by dividing (a) the Purchase Price, plus an amount equal to 8.75% of the Purchase Price per year, compounded annually, by (b) the conversion price in effect at the time of conversion. Each Preferred Share is initially convertible based on a conversion price of $7.13, subject to adjustment for certain distributions and other transactions by the Issuer on or with respect to the Common Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents series A participating convertible preferred shares (the \"Preferred Shares\") purchased by Roivant Sciences Ltd. (\"Roivant\") for $100.00 per Preferred Share (the \"Purchase Price\"), which price is subject to increase to reflect the addition of any unpaid participating cash dividends and unpaid participating in-kind dividends."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to earlier conversion at Roivant's option upon the occurrence of certain limited events set forth in the amendment to the Notice of Articles and the Articles of the Issuer (the \"Preferred Shares Articles Amendment\"), the Preferred Shares mandatorily convert on October 16, 2021, to the extent not already converted, into (i) unpaid accrued participating in-kind dividends and cash for any unpaid accrued cash dividends, as set forth in the Preferred Shares Article Amendment, and (ii) common shares of the Issuer, no par value (the \"Common Shares\"), which is determined by dividing (a) the Purchase Price, plus an amount equal to 8.75% of the Purchase Price per year, compounded annually, by (b) the conversion price in effect at the time of conversion. Each Preferred Share is initially convertible based on a conversion price of $7.13, subject to adjustment for certain distributions and other transactions by the Issuer on or with respect to the Common Shares."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents series A participating convertible preferred shares (the \"Preferred Shares\") purchased by Roivant Sciences Ltd. (\"Roivant\") for $100.00 per Preferred Share (the \"Purchase Price\"), which price is subject to increase to reflect the addition of any unpaid participating cash dividends and unpaid participating in-kind dividends."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Subject to earlier conversion at Roivant's option upon the occurrence of certain limited events set forth in the amendment to the Notice of Articles and the Articles of the Issuer (the \"Preferred Shares Articles Amendment\"), the Preferred Shares mandatorily convert on October 16, 2021, to the extent not already converted, into (i) unpaid accrued participating in-kind dividends and cash for any unpaid accrued cash dividends, as set forth in the Preferred Shares Article Amendment, and (ii) common shares of the Issuer, no par value (the \"Common Shares\"), which is determined by dividing (a) the Purchase Price, plus an amount equal to 8.75% of the Purchase Price per year, compounded annually, by (b) the conversion price in effect at the time of conversion. Each Preferred Share is initially convertible based on a conversion price of $7.13, subject to adjustment for certain distributions and other transactions by the Issuer on or with respect to the Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\"). VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Persons do not directly own any equity securities of the Issuer. The Reporting Persons acquired Roivant common shares on December 8, 2015. Roivant directly holds the 1,164,000 Preferred Shares reported herein. Due to certain governance arrangements set forth in Roivant's bye-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's bye-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Preferred Shares held by Roivant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"VGP is the general partner of VGE and VGE II and the investment manager of VGE III. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":1164000,"derivative":{"exercise_price":7.13,"expiration_date":"2021-10-16","underlying":"Common shares, no par value","underlying_shares":13025536},"source":{"system":"sec-edgar","filing":"0000903423-18-000018","document":"vikingf4aurbtusfirstt.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342318000018/vikingf4aurbtusfirstt.xml","form_type":"4"}},{"id":4185088,"issuer":{"id":4953,"kind":"organization","name":"Arbutus Biopharma Corp","symbol":"ABUS"},"owners":[{"id":89796,"kind":"organization","name":"VIKING GLOBAL PERFORMANCE LLC","position":1,"cik":"0001132625","reported_name":"VIKING GLOBAL PERFORMANCE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156035,"kind":"organization","name":"Viking Global Equities LP","position":2,"cik":"0001101785","reported_name":"Viking Global Equities LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89797,"kind":"organization","name":"Viking Global Equities II LP","position":3,"cik":"0001413378","reported_name":"Viking Global Equities II LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":156036,"kind":"organization","name":"VGE III Portfolio Ltd.","position":4,"cik":"0001621620","reported_name":"VGE III Portfolio Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111927,"kind":"organization","name":"Viking Long Fund Master Ltd.","position":5,"cik":"0001621596","reported_name":"Viking Long Fund Master Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":111928,"kind":"organization","name":"Viking Long Fund GP LLC","position":6,"cik":"0001621607","reported_name":"Viking Long Fund GP LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Participating Convertible Preferred Shares","published_at":"2017-10-17T08:54:33.000Z","date":"2017-10-16","kind":"purchase","acquired":true,"shares":500000,"price":100,"value":50000000.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents series A participating convertible preferred shares (the \"Preferred Shares\") purchased by Roivant Sciences Ltd. (\"Roivant\") for $100.00 per Preferred Share (the \"Purchase Price\"), which price is subject to increase to reflect the addition of any unpaid participating cash dividends and unpaid participating in-kind dividends."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Subject to earlier conversion at Roivant's option upon the occurrence of certain limited events set forth in the amendment to the Notice of Articles and the Articles of the Issuer (the \"Preferred Shares Articles Amendment\"), the Preferred Shares mandatorily convert on October 16, 2021, to the extent not already converted, into (i) unpaid accrued participating in-kind dividends and cash for any unpaid accrued cash dividends, as set forth in the Preferred Shares Article Amendment, and (ii) common shares of the Issuer, no par value (the \"Common Shares\"), which is determined by dividing (a) the Purchase Price, plus an amount equal to 8.75% of the Purchase Price per year, compounded annually, by (b) the conversion price in effect at the time of conversion. Each Preferred Share is initially convertible based on a conversion price of $7.13, subject to adjustment for certain distributions and other transactions by the Issuer on or with respect to the Common Shares."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents series A participating convertible preferred shares (the \"Preferred Shares\") purchased by Roivant Sciences Ltd. (\"Roivant\") for $100.00 per Preferred Share (the \"Purchase Price\"), which price is subject to increase to reflect the addition of any unpaid participating cash dividends and unpaid participating in-kind dividends."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to earlier conversion at Roivant's option upon the occurrence of certain limited events set forth in the amendment to the Notice of Articles and the Articles of the Issuer (the \"Preferred Shares Articles Amendment\"), the Preferred Shares mandatorily convert on October 16, 2021, to the extent not already converted, into (i) unpaid accrued participating in-kind dividends and cash for any unpaid accrued cash dividends, as set forth in the Preferred Shares Article Amendment, and (ii) common shares of the Issuer, no par value (the \"Common Shares\"), which is determined by dividing (a) the Purchase Price, plus an amount equal to 8.75% of the Purchase Price per year, compounded annually, by (b) the conversion price in effect at the time of conversion. Each Preferred Share is initially convertible based on a conversion price of $7.13, subject to adjustment for certain distributions and other transactions by the Issuer on or with respect to the Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents series A participating convertible preferred shares (the \"Preferred Shares\") purchased by Roivant Sciences Ltd. (\"Roivant\") for $100.00 per Preferred Share (the \"Purchase Price\"), which price is subject to increase to reflect the addition of any unpaid participating cash dividends and unpaid participating in-kind dividends."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Subject to earlier conversion at Roivant's option upon the occurrence of certain limited events set forth in the amendment to the Notice of Articles and the Articles of the Issuer (the \"Preferred Shares Articles Amendment\"), the Preferred Shares mandatorily convert on October 16, 2021, to the extent not already converted, into (i) unpaid accrued participating in-kind dividends and cash for any unpaid accrued cash dividends, as set forth in the Preferred Shares Article Amendment, and (ii) common shares of the Issuer, no par value (the \"Common Shares\"), which is determined by dividing (a) the Purchase Price, plus an amount equal to 8.75% of the Purchase Price per year, compounded annually, by (b) the conversion price in effect at the time of conversion. Each Preferred Share is initially convertible based on a conversion price of $7.13, subject to adjustment for certain distributions and other transactions by the Issuer on or with respect to the Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents series A participating convertible preferred shares (the \"Preferred Shares\") purchased by Roivant Sciences Ltd. (\"Roivant\") for $100.00 per Preferred Share (the \"Purchase Price\"), which price is subject to increase to reflect the addition of any unpaid participating cash dividends and unpaid participating in-kind dividends."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to earlier conversion at Roivant's option upon the occurrence of certain limited events set forth in the amendment to the Notice of Articles and the Articles of the Issuer (the \"Preferred Shares Articles Amendment\"), the Preferred Shares mandatorily convert on October 16, 2021, to the extent not already converted, into (i) unpaid accrued participating in-kind dividends and cash for any unpaid accrued cash dividends, as set forth in the Preferred Shares Article Amendment, and (ii) common shares of the Issuer, no par value (the \"Common Shares\"), which is determined by dividing (a) the Purchase Price, plus an amount equal to 8.75% of the Purchase Price per year, compounded annually, by (b) the conversion price in effect at the time of conversion. Each Preferred Share is initially convertible based on a conversion price of $7.13, subject to adjustment for certain distributions and other transactions by the Issuer on or with respect to the Common Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents series A participating convertible preferred shares (the \"Preferred Shares\") purchased by Roivant Sciences Ltd. (\"Roivant\") for $100.00 per Preferred Share (the \"Purchase Price\"), which price is subject to increase to reflect the addition of any unpaid participating cash dividends and unpaid participating in-kind dividends."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to earlier conversion at Roivant's option upon the occurrence of certain limited events set forth in the amendment to the Notice of Articles and the Articles of the Issuer (the \"Preferred Shares Articles Amendment\"), the Preferred Shares mandatorily convert on October 16, 2021, to the extent not already converted, into (i) unpaid accrued participating in-kind dividends and cash for any unpaid accrued cash dividends, as set forth in the Preferred Shares Article Amendment, and (ii) common shares of the Issuer, no par value (the \"Common Shares\"), which is determined by dividing (a) the Purchase Price, plus an amount equal to 8.75% of the Purchase Price per year, compounded annually, by (b) the conversion price in effect at the time of conversion. Each Preferred Share is initially convertible based on a conversion price of $7.13, subject to adjustment for certain distributions and other transactions by the Issuer on or with respect to the Common Shares."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents series A participating convertible preferred shares (the \"Preferred Shares\") purchased by Roivant Sciences Ltd. (\"Roivant\") for $100.00 per Preferred Share (the \"Purchase Price\"), which price is subject to increase to reflect the addition of any unpaid participating cash dividends and unpaid participating in-kind dividends."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Subject to earlier conversion at Roivant's option upon the occurrence of certain limited events set forth in the amendment to the Notice of Articles and the Articles of the Issuer (the \"Preferred Shares Articles Amendment\"), the Preferred Shares mandatorily convert on October 16, 2021, to the extent not already converted, into (i) unpaid accrued participating in-kind dividends and cash for any unpaid accrued cash dividends, as set forth in the Preferred Shares Article Amendment, and (ii) common shares of the Issuer, no par value (the \"Common Shares\"), which is determined by dividing (a) the Purchase Price, plus an amount equal to 8.75% of the Purchase Price per year, compounded annually, by (b) the conversion price in effect at the time of conversion. Each Preferred Share is initially convertible based on a conversion price of $7.13, subject to adjustment for certain distributions and other transactions by the Issuer on or with respect to the Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"O. Andreas Halvorsen, David C. Ott and Rose S. Shabet are Executive Committee members of certain management entities, including Viking Global Partners LLC, the general partner of Viking Global Investors LP (\"VGI\"), Viking Global Performance LLC (\"VGP\"), Viking Long Fund GP LLC (\"VLFGP\") and Viking Global Opportunities GP LLC (\"Opportunities GP\"), the sole owner of Viking Global Opportunities Portfolio GP LLC (\"Opportunities Portfolio GP\"). VGI provides managerial services to various investment funds, including Viking Global Equities LP (\"VGE\"), Viking Global Equities II LP (\"VGE II\"), VGE III Portfolio Ltd. (\"VGE III\"), Viking Long Fund Master Ltd. (\"VLFM\") and Viking Global Opportunities Illiquid Investments Sub-Master LP (\"Opportunities Fund\", and together with VGE, VGE II, VGE III and VLFM, the \"Funds\" and the Funds together with VGI, VGP, VLFGP, Opportunities GP, Opportunities Portfolio GP, O. Andreas Halvorsen, David C. Ott and Rose S. Shabet, the \"Reporting Persons\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Persons do not directly own any equity securities of the Issuer. The Reporting Persons acquired Roivant common shares on December 8, 2015. Roivant directly holds the 500,000 Preferred Shares reported herein. Due to certain governance arrangements set forth in Roivant's bye-laws, as of the appointment of an independent director (within the meaning of that term under Roivant's bye-laws) to Roivant's board of directors effective July 8, 2016, the Reporting Persons may be deemed to have beneficial ownership over the Preferred Shares held by Roivant."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"VGP is the general partner of VGE and VGE II and the investment manager of VGE III. VLFGP serves as the investment manager of VLFM. Opportunities GP serves as the sole member of Opportunities Portfolio GP. Opportunities Portfolio GP serves as the general partner of Opportunities Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Persons disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":500000,"derivative":{"exercise_price":7.13,"expiration_date":"2021-10-16","underlying":"Common shares, no par value","underlying_shares":9808386},"source":{"system":"sec-edgar","filing":"0000903423-17-000618","document":"vikingf4aurbtusfirstt.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101785/000090342317000618/vikingf4aurbtusfirstt.xml","form_type":"4"}}]}